cDC1s represent a subset specialized in cross-presenting tumor antigens on MHC-I molecules to CD8+ T lymphocytes for the generation of efficient cytotoxic T cell (CTL)-mediated immunity (for a review, [22,23]). Here, CD8A is linked to neoplasm.